Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8281ac9f4fb11f15a5da018344453338 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06139 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078 |
filingDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b6ed45e9b7c460b77f389fc284343f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90b742bfd89cef8fcedaa7ab833708ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_664448a1ba6c9801b1e4d62c7c472c7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c79fd34cb3c5cd07f1be93696003bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8a3f3873f5921eb9f57df16e0757df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89784646ac229f40d566d9173a1cb575 |
publicationDate |
2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022048944-A1 |
titleOfInvention |
Functionalized peptides as antiviral agents |
abstract |
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof:which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable slat thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof. |
priorityDate |
2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |